Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|February 22, 2012
A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancerDaniel J Renouf, Stephen Welch, Malcolm J Moore, et al.
BMJ Open|July 24, 2021
Ethical frameworks in clinical research processes during COVID-19: a scoping reviewLawrence Kasherman, Ainhoa Madariaga, Qin Liu, et al.
International Journal of Audiology|March 21, 2018
Targeting the psychosocial and functional fitness challenges of older adults with hearing loss: a participatory approach to adaptation of the walk and talk for your life programMarc Jutras, Justin Lambert, Jiyoung Hwang, et al.
Nature Medicine|June 30, 2022
Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics dataRuishan Liu, Shemra Rizzo, Sarah Waliany, et al.
Investigational New Drugs|April 29, 2011
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancerDaniel J Renouf, Patricia A Tang, Pierre Major, et al.
Human Mutation|September 8, 2007
Association of IL4R gene polymorphisms with asthma in Chinese populationsHaibing Zhang, Qu Zhang, Liming Wang, et al.
Journal of the National Cancer Institute|February 22, 2021
Underreporting of Symptomatic Adverse Events in Phase I Clinical TrialsZachary W Veitch, Daniel Shepshelovich, Christina Gallagher, et al.
The Oncologist|August 5, 2010
A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortiumSara K Taylor, Stephen Chia, Susan Dent, et al.
Gynecologic Oncology|May 25, 2015
Stage I granulosa cell tumours: A management conundrum? Results of long-term follow upMichelle K Wilson, Peter Fong, Soizick Mesnage, et al.
Targeted Oncology|May 31, 2022
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket StudyAbdulazeez Salawu, Aaron R Hansen, Anna Spreafico, et al.
Pageof 17